Concepedia

Jean Hurteau

JH

Statistics

Publications

55

Citations

4.1K

H-Index

33

Active since

1994

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Endeavor Health

University of Chicago

Indiana University School of Medicine

Roswell Park Comprehensive Cancer Center

Jean Hurteau is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and gynecologic oncology.

Publications per year

1994–2023

55

Publications

55

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

Joyce F. Liu, William T. Barry, Michael J. Birrer et al. · The Lancet Oncology · 2014 · 584 citations · Full text

Medicine, Gynecology, Oncology +16

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

Loren K. Mell, J.D. Kochanski, John C. Roeske et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 331 citations

Medicine, Oncology, Radiation Oncology +17

Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.

Yan Xu, Douglas C. Gaudette, Jessica Boynton et al. · PubMed · 1995 · 324 citations

Medicine, Biochemistry, Oncology +15

Bleomycin, Etoposide, and Cisplatin Combination Therapy of Ovarian Granulosa Cell Tumors and Other Stromal Malignancies: A Gynecologic Oncology Group Study

Howard D. Homesley, Brian N. Bundy, Jean Hurteau et al. · Gynecologic Oncology · 1999 · 251 citations

Medicine, Gynecology, Oncology +14

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer

J.F. Liu, William T. Barry, Michael J. Birrer et al. · Annals of Oncology · 2019 · 189 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–5 of 55